We have long talked about ‘fishy relationship’ between doctors and pharmaceutical companies, which might have contributed to high medical costs in the country. This week, Tempo magazine published its so-called ‘investigation’ into such practice by Kalbe Farma (KLBF), the largest pharmaceutical company listed on Indonesia Stock Exchange (IDX) with market capitalization of slightly above US$5 billion.To subscribe please click here